Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/91509
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Conference item |
Title: | A pilot study to assess the impact of patient, genetic and disease factors on response to the disease modifying anti-rheumatic drug leflunomide |
Author: | Wiese, M. Hopkins, A. Spargo, L. McWilliams, L. O'Doherty, C. Cleland, L. Proudman, S. |
Citation: | Internal Medicine Journal, 2014, vol.44, iss.Suppl. S2, pp.3-3 |
Publisher: | Wiley-Blackwell |
Issue Date: | 2014 |
ISSN: | 1444-0903 1445-5994 |
Conference Name: | Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania) |
Statement of Responsibility: | Wiese M, Hopkins A, Spargo L, McWilliams L, O, Doherty C, Cleland L, Proudman S |
Description: | Oral abstract ARA9 |
Rights: | © 2014 The Authors |
DOI: | 10.1111/imj.12424 |
Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.